Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
76-90 of 137
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CEChairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Benjamin Levy, MD
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CEPatients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Komal Jhaveri, MD, FACP
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Giuseppe Curigliano, MD, PhD
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
MinuteCE®Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Giuseppe Curigliano, MD, PhD
- advertisement
Routes Reconsidered: A Case-Based Debate in SERD Selection
MinuteCE®Routes Reconsidered: A Case-Based Debate in SERD Selection
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
MinuteCE®Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
MinuteCE®Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
Komal Jhaveri, MD, FACP
The Future of Oral SERDs: Combination Strategies
MinuteCE®The Future of Oral SERDs: Combination Strategies
Komal Jhaveri, MD, FACP
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®Spotlight on Asia-Pacific: Practice Beyond Borders
Hiraji Iwata, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
- advertisement
Giuseppe Curigliano, MD, PhD
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
MinuteCE®Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
Luis Paz-Ares, MD, PhD
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
MinuteCE®Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
Lauren A. Byers, MD